New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Bio-One Receives $30 Million Equity Commitment

ORLANDO, Fla., Mar 9, 2004 /PRNewswire-FirstCall via COMTEX/ -- Bio-One Corporation (OTC Bulletin Board: BICO) announced today that the company has successfully negotiated an agreement for a $30 million equity investment. The share price on the first $15 million will be determined at the conclusion of a 30 day, 60 day and 90 day period. The share price on the second $15 million is $.75 per share.

The first $15 million will be received upon signing of the final closing documents, which is anticipated to be within 30 days. The second $15 million is expected during the third quarter of this year.

Bio-One President and CEO Armand Dauplaise said, "The initial $15 million will enable us to immediately close on two recently announced acquisitions. We are acquiring 100% of an international leader in the manufacturing and distribution of branded, specialty, nutritional supplements. This $12 million annual revenue business enjoys an outstanding reputation for consistent high quality and product development. They market their products in Canada, Hong Kong and the United States. Their profitability is double the average for U.S. supplement businesses. The company will continue to be run by its present management team."

Dauplaise said, "We will also be in a position to close on a 51% interest in the leading manufacturer and distributor of glucose in China, which possesses a 30% market share. The Chinese business, which holds three patents, reported 2003 revenues of $17 million and EBITDA of 22% and has assets of $17 million. Purchase terms include cash and convertible preferred stock at $2.00 per share, with lock-up terms regarding sale. The 450-employee company will continue to be run by its present management team. The People's Republic of China joint venture documents have been signed and the certified audits are completed."

Dauplaise added, "The availability of the additional $15 million in the third quarter of this year will enable us to continue to aggressively build a major company through acquisition and organic growth via vertical integration of manufacturing, distribution and marketing."

About Bio-One

Bio-One Corporation, a nutritional supplements company serving the preventive and alternative healthcare segments, is rapidly expanding through an aggressive global acquisition strategy. The company is selectively acquiring industry leaders in order to provide quality nutraceuticals to consumers through vertical integration of manufacturing, distribution and marketing. Since September 2003, the company has acquired PNLabs and American Nutritional Exchange with projected 2004 revenue of $20 million. Bio-One also has executed letters of intent to acquire ownership or majority control of four other companies with combined annual revenue of $53 million. The company says it is in discussions with several acquisition candidates.

Bio-One is targeting companies with less than $25 million in annual sales. The company's home state, Florida, ranks first nationally in per capita consumption of nutritional supplements and second only to California in total industry sales. Bio-One's goals are threefold: 1) to serve people worldwide who desire vitality and longevity; 2) to interface a quality and value growth philosophy through the acquisition of selected businesses; 3) to provide a superior return on investment for company shareholders.

Bio-One Corporation is committed to its mission of the continuing pursuit of excellence in serving our customers, our suppliers, our team members and our shareholders. Bio-One is confident that it will accomplish its mission and goals through the application of its management philosophy, which is to treat others the way they would want to be treated themselves.

An investment profile on Bio-One Corporation may be found at

For investor relations information, contact Frank Hawkins or Julie Marshall, Hawk Associates at (305) 852-2383. Email: For Bio-One information contact Bob Gartzman at 888-327-4703. Detailed information about Bio-One may be found on the website Copies of Bio-One press releases, current Level II price quotes, interactive and java stock charts and other valuable information for investors may be found on the websites and

Certain statements released by Bio-One Corporation that are forward- looking statements are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Editors and investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the company's business prospects and performance. These include, but are not limited to, economic, competitive, governmental, technological and other risks detailed in the company's registration statements and periodic reports filed with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.